Korean J Intern Med.
2014 Nov;29(6):827-829. 10.3904/kjim.2014.29.6.827.
Persistent suboptimal molecular response in a patient with chronic myelogenous leukemia and Klinefelter syndrome
- Affiliations
-
- 1Department of Internal Medicine, Queens Hospital Center, Icahn School of Medicine at Mount Sinai, Jamaica, NY, USA. rajshekhar.ucms@gmail.com
- KMID: 2070143
- DOI: http://doi.org/10.3904/kjim.2014.29.6.827
Abstract
- No abstract available.
MeSH Terms
-
Adult
Antineoplastic Agents/therapeutic use
*Chromosome Deletion
*Chromosomes, Human, Pair 9
Cytogenetic Analysis
DNA Mutational Analysis
Fusion Proteins, bcr-abl/*antagonists & inhibitors/genetics/metabolism
Gene Expression Regulation
Humans
Incidental Findings
Klinefelter Syndrome/complications/diagnosis/*genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/complications/diagnosis/*drug therapy/enzymology/genetics
Male
Molecular Targeted Therapy
Protein Kinase Inhibitors/*therapeutic use
Remission Induction
Time Factors
Treatment Outcome
Antineoplastic Agents
Fusion Proteins, bcr-abl
Protein Kinase Inhibitors
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Sweet's Syndrome with Myelodysplastic Syndrome Progressing to Acute Myelogenous Leukemia
- Acute Myeloid Leukemia with the 11q23 Rearrangement in a Patient with Klinefelter Syndrome
- The role of early molecular predictor in transplant-eligible chronic myelogenous leukemia
- Development of peripheral T-cell lymphoma in the course of chronic myelogenous leukemia
- Sudden Hearing Loss in Chronic Myelogenous Leukemia Implicating Hyperviscosity Syndrome
